European research indicates that patients with COPD appear to demonstrate gray matter decreases in areas of the brain that are relevant for the processing of dyspnea, fear, and anti-nociception. The observed changes were related in part to longer disease duration and greater disease-specific fears, according to the authors.
Source: Chest, July 23, 2015.
